z-logo
Premium
Perinatal outcomes of single fetal survivor after fetal intervention for complicated monochorionic twins
Author(s) -
Hoffman Mallory,
Habli Mounira,
Donepudi Roopali,
Boring Noemi,
Johnson Anthony,
Moise Kenneth J.,
Papanna Ramesha
Publication year - 2018
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.5278
Subject(s) - medicine , monochorionic twins , fetoscopy , obstetrics , gestational age , fetus , twin to twin transfusion syndrome , rupture of membranes , pregnancy , prenatal diagnosis , genetics , biology
Objective To compare perinatal outcomes between acute single fetal demise following fetoscopic laser photocoagulation to planned selective reduction (SR) in complicated monochorionic twin pregnancies. Methods This was a secondary analysis of prospectively collected data in complicated monochorionic twin pregnancies from 2 fetal centers from 2011 to 2016. Group 1 included women undergoing fetoscopic laser photocoagulation for twin‐twin transfusion syndrome (TTTS) who experienced a single fetal demise within 24 hours of the procedure. Group 2 consisted of women undergoing planned selective reduction (SR) with TTTS, and Group 3 SR for indications other than TTTS. Results Survival of the remaining co‐twin at birth was highest in Group 1 (n = 77 patients; 95%) compared with that in Group 2 ( n  = 15; 80%) and Group 3 ( n  = 32; 78%; P  = .047). The preterm premature rupture of membrane rate was higher in Group 1 (47%) compared with that in Group 2 (33%) and Group 3 (7%; P  < .001). Group 1 had a lower gestational age at delivery and shorter procedure‐to‐delivery interval compared with the other 2 groups ( P  < .01). Conclusion When single fetal demise occurs following fetoscopic laser photocoagulation, the surviving co‐twin is more likely to survive to delivery but has higher PPROM rates and a shorter latency period compared with planned selective reduction for TTTS or other indications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here